National Center for Advancing Translational Sciences in Virginia
National Center for Advancing Translational Sciences (93.350) awarded $40.4 million to recipients in Virginia in 24 grants from fiscal 2021 to 2025, 1.3% of the program's national total. Virginia Commonwealth University received the most, $25.4 million.
- Awarded in Virginia$40.4 million
- Awards24
- Share of the program1.3%
- Rank among states23rd of 41
- National total$3.1 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 11 | $10.7 million |
| FY 2022 | 11 | $10.3 million |
| FY 2023 | 9 | $8.9 million |
| FY 2024 | 6 | $4.6 million |
| FY 2025 | 6 | $5.9 million |
Recipients in Virginia
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Virginia Commonwealth University | Colleges and universities | 12 | $25.4 million |
| Rector & Visitors of the University of Virginia | Colleges and universities | 6 | $14.0 million |
| Onca Bio, Inc. | Small businesses | 1 | $348,848 |
| Pak Biosolutions, Inc. | Small businesses | 1 | $311,338 |
| Affinity Molecules ,LLC | Small businesses | 1 | $297,193 |
| Association of Clinical Research Professionals, Inc. | Nonprofits | 1 | $25,000 |
| George Mason University | Colleges and universities | 2 | $18,590 |
Open opportunities under this program
- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
- Limited Competition: NCATS Clinical and Translational Science Award (CTSA) Program Research Education Grants Programs (R25 - Clinical Trial Not Allowed)
- Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
- Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
- NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
- Clinical and Translational Science Award (UM1 Clinical Trial Optional)
- Limited Competition: Mentored Research Career Development Program Award in Clinical and Translational Science Awards (CTSA) Program (K12 Clinical Trial Optional)
See all 34 on the program page
Questions people ask
How much National Center for Advancing Translational Sciences money goes to Virginia?
$40.4 million from fiscal 2021 to 2025, across 24 awards. Virginia ranks 23rd of 41 states and territories for this program.
Who receives National Center for Advancing Translational Sciences money in Virginia?
The largest recipient is Virginia Commonwealth University, with $25.4 million in 12 awards. Next are Rector & Visitors of the University of Virginia and Onca Bio, Inc..
Can organizations in Virginia apply now?
Yes, 34 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
National Center for Advancing Translational Sciences in other states
Other large programs in Virginia
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Children's Health Insurance Program
- Special Education Grants to States
- Child Care and Development Block Grant
- Title I Grants to Local Educational Agencies
- Broadband Equity, Access, and Deployment Program
- Emergency Food and Shelter National Board Program